Overexpression of the ERBB/EGFR family of proteins occurs in up to 90% of pancreatic ductal adenocarcinomas (PDA) and 60% of biliary tract cancers (BTC) and has been associated with more aggressive biology and inferior survival [1,2]. This evidence concerns the gene EGFR and biliary tract neoplasm.